» Articles » PMID: 31189557

Global Extraintestinal Pathogenic Escherichia Coli (ExPEC) Lineages

Overview
Specialty Microbiology
Date 2019 Jun 14
PMID 31189557
Citations 238
Authors
Affiliations
Soon will be listed here.
Abstract

Extraintestinal pathogenic (ExPEC) strains are responsible for a majority of human extraintestinal infections globally, resulting in enormous direct medical and social costs. ExPEC strains are comprised of many lineages, but only a subset is responsible for the vast majority of infections. Few systematic surveillance systems exist for ExPEC. To address this gap, we systematically reviewed and meta-analyzed 217 studies (1995 to 2018) that performed multilocus sequence typing or whole-genome sequencing to genotype recovered from extraintestinal infections or the gut. Twenty major ExPEC sequence types (STs) accounted for 85% of isolates from the included studies. ST131 was the most common ST from 2000 onwards, covering all geographic regions. Antimicrobial resistance-based isolate study inclusion criteria likely led to an overestimation and underestimation of some lineages. European and North American studies showed similar distributions of ExPEC STs, but Asian and African studies diverged. Epidemiology and population dynamics of ExPEC are complex; summary proportion for some STs varied over time (e.g., ST95), while other STs were constant (e.g., ST10). Persistence, adaptation, and predominance in the intestinal reservoir may drive ExPEC success. Systematic, unbiased tracking of predominant ExPEC lineages will direct research toward better treatment and prevention strategies for extraintestinal infections.

Citing Articles

Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses.

Caddey B, Fisher S, Barkema H, Nobrega D Clin Microbiol Rev. 2025; 38(1):e0014622.

PMID: 39853095 PMC: 11905369. DOI: 10.1128/cmr.00146-22.


ESBL- and pAmpC-producing Enterobacterales from Swedish dogs and cats 2017-2021: a retrospective study.

Bonnevie A, Myrenas M, Nilsson O Acta Vet Scand. 2025; 67(1):2.

PMID: 39762972 PMC: 11702106. DOI: 10.1186/s13028-024-00786-2.


Characteristics of the extended-spectrum-β-lactamase-producing Escherichia coli isolated from diseased livestock and poultry in Taiwan.

Kuan N, Chen Y, Shien J, Yeh K Sci Rep. 2024; 14(1):29459.

PMID: 39604539 PMC: 11603147. DOI: 10.1038/s41598-024-80943-9.


Chromosomal Type II Toxin-Antitoxin Systems May Enhance Bacterial Fitness of a Hybrid Pathogenic Strain Under Stress Conditions.

Silva J, Marques-Neto L, Carvalho E, Del Carpio A, Henrique C, Leite L Toxins (Basel). 2024; 16(11).

PMID: 39591224 PMC: 11598369. DOI: 10.3390/toxins16110469.


Emergence of ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.

Kohlenberg A, Svartstrom O, Apfalter P, Hartl R, Bogaerts P, Huang T Euro Surveill. 2024; 29(47).

PMID: 39574387 PMC: 11583312. DOI: 10.2807/1560-7917.ES.2024.29.47.2400727.


References
1.
Turck M, Petersdorf R . The epidemiology of nonenteric Escherichia coli infections: prevalence of serological groups. J Clin Invest. 1962; 41:1760-5. PMC: 291099. DOI: 10.1172/JCI104635. View

2.
Ha Y, Kang C, Cha M, Park S, Wi Y, Chung D . Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013; 42(5):403-9. DOI: 10.1016/j.ijantimicag.2013.07.018. View

3.
Pomba C, Lopez-Cerero L, Bellido M, Serrano L, Belas A, Couto N . Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe. J Antimicrob Chemother. 2013; 69(1):271-3. DOI: 10.1093/jac/dkt343. View

4.
Musicha P, Feasey N, Cain A, Kallonen T, Chaguza C, Peno C . Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting. J Antimicrob Chemother. 2017; 72(6):1602-1609. PMC: 5437524. DOI: 10.1093/jac/dkx058. View

5.
Kumarasamy K, Toleman M, Walsh T, Bagaria J, Butt F, Balakrishnan R . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10(9):597-602. PMC: 2933358. DOI: 10.1016/S1473-3099(10)70143-2. View